MYL : NASDAQ : Health Care
$36.51 | %
Today's Range: 36.07 - 37.15
Avg. Daily Volume: 6816800.0
12/09/16 - 4:00 PM ET

Financial Analysis


MYLAN NV's gross profit margin for the third quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. Even though sales increased, the net income has decreased, representing a decrease to the bottom line. MYLAN NV has very weak liquidity. Currently, the Quick Ratio is 0.47 which clearly shows a lack of ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year.

During the same period, stockholders' equity ("net worth") has increased by 20.51% from the same quarter last year. The key liquidity measurements indicate that the company is in a position in which financial difficulties could develop in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q3 FY16 Q3 FY15
Net Sales ($mil)3057.12695.2
EBITDA ($mil)977.8937.3
EBIT ($mil)531.9679.6
Net Income ($mil)-119.8428.6


Balance Sheet Q3 FY16 Q3 FY15
Cash & Equiv. ($mil)1413.4693.5
Total Assets ($mil)36538.521316.5
Total Debt ($mil)15817.46348.6
Equity ($mil)11827.39813.6


Profitability Q3 FY16 Q3 FY15
Gross Profit Margin57.5559.48
EBITDA Margin31.9834.77
Operating Margin17.425.22
Sales Turnover0.280.42
Return on Assets0.73.95
Return on Equity2.178.58
Debt Q3 FY16 Q3 FY15
Current Ratio0.831.76
Debt/Capital0.570.39
Interest Expense24.355.0
Interest Coverage21.8912.36


Share Data Q3 FY16 Q3 FY15
Shares outstanding (mil)535.07491.74
Div / share0.00.0
EPS-0.230.83
Book value / share22.119.96
Institutional Own % n/a n/a
Avg Daily Volume6700069.05564334.0

Valuation


HOLD. MYLAN NV's P/E ratio indicates a significant premium compared to an average of 26.06 for the Pharmaceuticals industry and a significant premium compared to the S&P 500 average of 25.37. To use another comparison, its price-to-book ratio of 1.61 indicates a discount versus the S&P 500 average of 2.81 and a significant discount versus the industry average of 63.67. The price-to-sales ratio is similar to the S&P 500 average, but it is significantly below the industry average, indicating a discount.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
MYL 69.90 Peers 26.06   MYL 7.91 Peers 18.01

Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.

MYL is trading at a significant premium to its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

MYL is trading at a significant discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
MYL 6.65 Peers 13.78   MYL 0.39 Peers 0.50

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

MYL is trading at a significant discount to its peers.

 

Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

MYL trades at a discount to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
MYL 1.61 Peers 63.67   MYL -70.86 Peers -15.36

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

MYL is trading at a significant discount to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, MYL is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
MYL 1.85 Peers 12.79   MYL 14.17 Peers 5.02

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

MYL is trading at a significant discount to its industry on this measurement.

 

Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

MYL has a sales growth rate that significantly exceeds its peers.

 

 

Latest Stock Upgrades/Downgrades